Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.68 |
| ▸ | GPR3 | P46089 | 2/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.56 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.56 |
| ▸ | AHR | P35869 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 2/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | ATM | Q13315 | 1/20 | 0.56 |
| ▸ | KIF11 | P52732 | 4/20 | 0.46 |
| ▸ | GABRP | O00591 | 2/20 | 0.46 |
| ▸ | GABRD | O14764 | 2/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.46 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.46 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.46 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.46 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbazole SCHEMBL7650 | 0.82 | ALDH1A1 (1.00) | ALDH1A1GPR3HSD17B10KDM4EHPGD | |
| Carbazole SCHEMBL370524 | 0.82 | ALDH1A1 (1.00) | ALDH1A1GPR3HSD17B10KDM4EHPGD | |
| Carbazole SCHEMBL30209164 | 0.82 | ALDH1A1 (1.00) | ALDH1A1GPR3HSD17B10KDM4EHPGD | |
| Carbazole SCHEMBL29627417 | 0.82 | ALDH1A1 (1.00) | ALDH1A1GPR3HSD17B10KDM4EHPGD | |
| Carbazole SCHEMBL30761795 | 0.82 | ALDH1A1 (1.00) | ALDH1A1GPR3HSD17B10KDM4EHPGD | |
| Carbazole SCHEMBL29355407 | 0.82 | ALDH1A1 (1.00) | ALDH1A1GPR3HSD17B10KDM4EHPGD | |
| SCHEMBL24058091 | 0.80 | GAA (0.64) | ALDH1A1GPR3HSD17B10KDM4EHPGD | |
| Carbazole SCHEMBL25328075 | 0.79 | ALDH1A1 (0.93) | ALDH1A1GPR3HSD17B10KDM4EHPGD | |
| Carbazole SCHEMBL25327723 | 0.79 | ALDH1A1 (0.93) | ALDH1A1GPR3HSD17B10KDM4EHPGD | |
| Carbazole SCHEMBL22712375 | 0.79 | ALDH1A1 (0.93) | ALDH1A1GPR3HSD17B10KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230263755-A1 | STABILIZATION OF ACETAMINOPHEN IN AQUEOUS SOLUTION | NOSTRUM PHARMACEUTICALS, LLC (US) | 2023-08-24 | — | — | US | disclosed |
| EP-3519386-B1 | NOVEL PI-CONJUGATED MATERIALS, METHODS FOR PREPARING SAME AND USES THEREOF AS SEMICONDUCTORS | DEGBIA MARTIAL (FR) | 2023-03-29 | — | — | EP | disclosed |
| US-9943479-B2 | Injectable liquid paracetamol formulation | GENFARMA LABORATORIO S.L. (ES) | 2018-04-17 | — | — | US | disclosed |
| US-9943492-B2 | Injectable liquid paracetamol formulation | GENFARMA LABORATORIO S.L. (ES) | 2018-04-17 | — | — | US | disclosed |
| EP-2609639-B1 | USE OF ZWITTERIONIC MOLECULES FOR FORMING A HOLE OR ELECTRON TRANSPORT LAYER | CENTRE NAT RECH SCIENT (FR) | 2016-10-05 | — | — | EP | disclosed |
| US-20160199325-A1 | INJECTABLE LIQUID PARACETAMOL FORMULATION | ALTAN PHARMACEUTICALS S.A.U. (ES) | 2016-07-14 | — | — | US | disclosed |
| EP-2277546-B1 | Stable ready to use injectable paracetamol formulation | UNI PHARMA KLEON TSETIS PHARMACEUTICAL LAB S A (GR) | 2015-07-15 | — | — | EP | disclosed |
| US-9006488-B1 | Solvent free synthesis of acetaminophen | AMIN MUHAMMAD (PK) | 2015-04-14 | — | — | US | disclosed |
| US-8877817-B2 | Stable ready to use injectable paracetamol formulation | TSETI IOULIA (GR) | 2014-11-04 | — | — | US | disclosed |
| US-20130210922-A1 | STABLE READY TO USE INJECTABLE PARACETAMOL FORMULATION | UNIPHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A. (GR) | 2013-08-15 | — | — | US | disclosed |
| US-20120190750-A1 | STABLE READY TO USE INJECTABLE PARACETAMOL FORMULATION | UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A. (GR) | 2012-07-26 | — | — | US | disclosed |
| CN-102600068-A | Stable ready-to-use injectable paracetamol formulation | LINCON PHARMACEUTICAL CRAINTSIRTIS PHARMACEUTICAL LAB S A | 2012-07-25 | — | — | CN | disclosed |
| EP-2389923-A1 | Stable ready to use injectable paracetamol formulation | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. (GR) | 2011-11-30 | — | — | EP | disclosed |
| WO-2011144335-A1 | STABLE READY TO USE INJECTABLE PARACETAMOL FORMULATION | UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A. (GR) | 2011-11-24 | — | — | WO | disclosed |
| WO-2011071400-A1 | METHOD AND COMPOSITION FOR PREPARING STABLE LIQUID FORMULATIONS OF PARACETAMOL | TECNIMEDE - SOCIEDADE TÉCNICO-MEDICINAL, S.A. (PT) | 2011-06-16 | — | — | WO | disclosed |
| EP-2277546-A1 | Stable ready to use injectable paracetamol formulation | Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. (GR) | 2011-01-26 | — | — | EP | disclosed |
| EP-2100596-A2 | Injectable liquid paracetamol formulation | Genfarma Laboratorio S.L. (ES) | 2009-09-16 | — | — | EP | disclosed |
| US-20090215903-A1 | Injectable Liquid Paracetamol Formulation | GES GENERICOS ESPAÑOLES LABORATORIO, S.A (ES) | 2009-08-27 | — | — | US | disclosed |
| EP-1889607-B1 | Injectable liquid paracetamol formulation | GENFARMA LAB S L (ES) | 2009-06-03 | — | — | EP | disclosed |
| EP-1889607-A1 | Injectable liquid paracetamol formulation | Genfarma Laboratorio S.L. (ES) | 2008-02-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160199325-A1 | INJECTABLE LIQUID PARACETAMOL FORMULATION | CYP3A5, CYP3A4, CYP2C9 | ALDH1A1 444/4885GPR3 1767/4885HSD17B10 1371/4885 |
| US-20090215903-A1 | Injectable Liquid Paracetamol Formulation | CYP3A7, CYP4F3, CYP3A5 | ALDH1A1 276/4885GPR3 3071/4885HSD17B10 121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.